Purpose : To report two cases of Irvine-Gass syndrome that responded to intravitreal injection of bevacizumab. Cases and Findings : Two males, aged 73 and 69 years, received phacoemulsification with intraocular lens implantation. Visual acuity improved to 0.8 and 1.2 but decreased to 0.2 and 0.6 after 3 weeks and 2 months respectively. Both cases showed cystoid macular edema (CME) and thickened fovea, leading to the diagnosis of Irvine-Gass syndrome. Intravitreal injection of bevacizumab was followed by resolution of CME after 2 and 1 week respectively. Visual acuity improved to 0.4 and 1.2 respectively. There has been no recurrence for 13 and 22 months until present. Conclusion : Intravitreal injection of bevacizumab may be effective for Irvine-Gass syndrome.Rinsho Ganka (Jpn J Clin Ophthalmol) 63(5): 801-805, 2009.
|Number of pages||5|
|Journal||Japanese Journal of Clinical Ophthalmology|
|Publication status||Published - Aug 5 2009|
ASJC Scopus subject areas